Daniel Patrick Walker

Person

Kalamazoo, MI, US

People

Patents Grantslast 30 patents

Information Patent Grant
Bruton's tyrosine kinase inhibitors
- Patent number 10,815,213
- Issue date Oct 27, 2020
- Pfizer Inc.
- John Robert Springer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
3,6-dichlorosalicylic acid compounds and related synthetic processes
- Patent number 10,807,936
- Issue date Oct 20, 2020
- Monsanto Technology LLC
- Terri L. Boehm
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Processes for the preparation of heteroaryl carboxylic acids
- Patent number 10,745,376
- Issue date Aug 18, 2020
- Monsanto Technology LLC
- Daniel Patrick Walker
- B01 - PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
Information Patent Grant
3,6-dichlorosalicylic acid compounds and related synthetic processes
- Patent number 10,519,092
- Issue date Dec 31, 2019
- Monsanto Technology LLC
- Terri L. Boehm
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bruton's tyrosine kinase inhibitors
- Patent number 10,266,513
- Issue date Apr 23, 2019
- Pfizer Inc.
- John Robert Springer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Processes for the preparation of 2-thiophenecarbonyl chloride
- Patent number 10,239,857
- Issue date Mar 26, 2019
- Monsanto Technology LLC
- Daniel P. Walker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
3,6-dichlorosalicylic acid compounds and related synthetic processes
- Patent number 9,856,201
- Issue date Jan 2, 2018
- Monsanto Technology LLC
- Terri L. Boehm
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrido[4,3-d]pyrimidin-4(3H)-one derivatives as calcium receptor an...
- Patent number 7,829,572
- Issue date Nov 9, 2010
- Pfizer Inc.
- Mary T. Didiuk
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
1H-pyrazole and 1H-pyrrole-azabicyclic compounds for the treatment...
- Patent number 7,176,198
- Issue date Feb 13, 2007
- Pfizer Inc.
- David W. Piotrowski
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Azabicyclic compounds for the treatment of disease
- Patent number 7,001,900
- Issue date Feb 21, 2006
- Pfizer Inc.
- Eric Jon Jacobsen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Azabicyclic-phenyl-fused-heterocyclic compounds for treatment of di...
- Patent number 6,951,868
- Issue date Oct 4, 2005
- Pfizer Inc.
- Daniel Patrick Walker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Azabicyclic-substituted-heteroaryl compounds for the treatment of d...
- Patent number 6,919,359
- Issue date Jul 19, 2005
- Pfizer Inc.
- David W. Piotrowski
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Azabicyclic-substituted fused-heteroaryl compounds for the treatmen...
- Patent number 6,911,543
- Issue date Jun 28, 2005
- Pfizer Inc.
- Daniel Patrick Walker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Azabicyclic compounds for the treatment of disease
- Patent number 6,894,042
- Issue date May 17, 2005
- Pharmacia and Upjohn Company
- Daniel Patrick Walker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted azabicyclic moieties for the treatment of disease
- Patent number 6,869,946
- Issue date Mar 22, 2005
- Pfizer Inc.
- Eric Jon Jacobsen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused bicyclic-N-bridged-heteroaromatic carboxamides for the treatm...
- Patent number 6,858,613
- Issue date Feb 22, 2005
- Pfizer Inc.
- Bruce N. Rogers
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted-aryl compounds for treatment of disease
- Patent number 6,852,716
- Issue date Feb 8, 2005
- Pfizer Inc.
- Daniel Patrick Walker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
N-(azabicyclo moieties)-substituted hetero-bicyclic aromatic compou...
- Patent number 6,849,620
- Issue date Feb 1, 2005
- Pfizer Inc.
- Daniel Patrick Walker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quinuclidine-substituted hetero-bicyclic aromatic compounds for the...
- Patent number 6,828,330
- Issue date Dec 7, 2004
- Pharmacia and Upjohn Company
- Daniel Patrick Walker
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
Bruton's Tyrosine Kinase Inhibitors
- Publication number 20210002251
- Publication date Jan 7, 2021
- Pfizer Inc.
- John Robert Springer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROCESSES FOR THE PREPARATION OF HETEROARYL CARBOXYLIC ACIDS
- Publication number 20200347026
- Publication date Nov 5, 2020
- Monsanto Technology LLC
- William Harold Miller
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3,6-DICHLOROSALICYLIC ACID COMPOUNDS AND RELATED SYNTHETIC PROCESSES
- Publication number 20200181055
- Publication date Jun 11, 2020
- Monsanto Technology LLC
- Terri L. Boehm
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Bruton's Tyrosine Kinase Inhibitors
- Publication number 20190202798
- Publication date Jul 4, 2019
- Pfizer Inc.
- John Robert Springer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROCESSES FOR THE PREPARATION OF HETEROARYL CARBOXYLIC ACIDS
- Publication number 20190062299
- Publication date Feb 28, 2019
- Monsanto Technology LLC
- Daniel Patrick Walker
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROCESSES FOR THE PREPARATION OF 2-THIOPHENECARBONYL CHLORIDE
- Publication number 20180162830
- Publication date Jun 14, 2018
- Monsanto Technology LLC
- Daniel P. Walker
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3,6-DICHLOROSALICYLIC ACID COMPOUNDS AND RELATED SYNTHETIC PROCESSES
- Publication number 20180155265
- Publication date Jun 7, 2018
- Monsanto Technology LLC
- Terri L. Boehm
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Bruton's Tyrosine Kinase Inhibitors
- Publication number 20170283393
- Publication date Oct 5, 2017
- Pfizer Inc.
- John Robert Springer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3,6-DICHLOROSALICYLIC ACID COMPOUNDS AND RELATED SYNTHETIC PROCESSES
- Publication number 20170190648
- Publication date Jul 6, 2017
- Monsanto Technology LLC
- Terri L. Boehm
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Bruton's Tyrosine Kinase Inhibitors
- Publication number 20150291554
- Publication date Oct 15, 2015
- Pfizer Inc.
- John Robert Springer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRIDO[4,3-d]PYRIMIDIN-4(3H)-ONE DERIVATIVES AS CALCIUM RECEPTOR AN...
- Publication number 20110028452
- Publication date Feb 3, 2011
- Pfizer Inc.
- Mary T. Didiuk
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRIDO [4,3-d] PYRIMIDIN-4 (3H) -ONE DERIVATIVES AS CALCIUM RECEPTO...
- Publication number 20080085887
- Publication date Apr 10, 2008
- Pfizer Inc.
- Mary T. Didiuk
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Exo-(t-butyl 2R(+))-2-amino-7-azabicyclo[2.2.1]heptane-7-carboxylat...
- Publication number 20060173063
- Publication date Aug 3, 2006
- Pfizer Inc.
- Thomas Lee Fevig
- C07 - ORGANIC CHEMISTRY
Information Patent Application
1H-pyrazole and 1h-pyrole-azabicyclic compounds for the treatment o...
- Publication number 20060116395
- Publication date Jun 1, 2006
- Pfizer Inc.
- David W. Piotrowski
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Positive allosteric modulators of the nicotinic acetylcholine receptor
- Publication number 20050250816
- Publication date Nov 10, 2005
- Pfizer Inc.
- David W. Piotrowski
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Azabicyclic-substituted fused heteroaryl compounds for the treatmen...
- Publication number 20050234092
- Publication date Oct 20, 2005
- Pfizer Inc.
- Daniel Patrick Walker
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Azabicyclic-substituted fused heteroaryl compounds for the treatmen...
- Publication number 20050222196
- Publication date Oct 6, 2005
- Pfizer Inc.
- Daniel Patrick Walker
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Fused bicyclic-N-bridged-heteroaromatic carboxamides for the treatm...
- Publication number 20050215584
- Publication date Sep 29, 2005
- Pfizer Inc.
- Bruce N. Rogers
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Treatment of attention defecit hyperactivity disorder
- Publication number 20050107425
- Publication date May 19, 2005
- Pfizer Inc.
- Bruce N. Rogers
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Quinuclidines-substituted-multi-cyclic-heteroaryls for treatment of...
- Publication number 20050059698
- Publication date Mar 17, 2005
- Pfizer Inc.
- Jon Gordon Selbo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Positive allosteric modulators of the nicotinic acetylcholine receptor
- Publication number 20040254373
- Publication date Dec 16, 2004
- Pfizer Inc.
- David W. Piotrowski
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Positive allosteric modulators of the nicotinic acetylcholine receptor
- Publication number 20040249150
- Publication date Dec 9, 2004
- Pfizer Inc.
- David W. Piotrowski
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Quinuclidine-substituted hetero-bicyclic aromatic compounds for the...
- Publication number 20040224977
- Publication date Nov 11, 2004
- Daniel Patrick Walker
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Azabicyclic compounds for the treatment of disease
- Publication number 20040224976
- Publication date Nov 11, 2004
- Daniel Patrick Walker
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds as radioligands for the diagnosis of disease
- Publication number 20040157878
- Publication date Aug 12, 2004
- Bruce Nelson Rogers
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds having both alpha7 nicotinic agonist activity and 5HT3 an...
- Publication number 20040147522
- Publication date Jul 29, 2004
- Erik Ho Fong Wong
- C07 - ORGANIC CHEMISTRY
Information Patent Application
1H-pyrazole and 1H-pyrrole-azabicyclic compounds for the treatment...
- Publication number 20040087616
- Publication date May 6, 2004
- David W. Piotrowski
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Azabicyclic compounds for the treatment of disease
- Publication number 20030236270
- Publication date Dec 25, 2003
- Eric Jon Jacobsen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Substituted-aryl compounds for treatment of disease
- Publication number 20030236279
- Publication date Dec 25, 2003
- Daniel Patrick Walker
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Fused bicyclic-N-bridged-heteroaromatic carboxamides for the treatm...
- Publication number 20030236264
- Publication date Dec 25, 2003
- Bruce N. Rogers
- C07 - ORGANIC CHEMISTRY

Daniel Patrick Walker

Person

Patents Grantslast 30 patents

Bruton's tyrosine kinase inhibitors

3,6-dichlorosalicylic acid compounds and related synthetic processes

Processes for the preparation of heteroaryl carboxylic acids

3,6-dichlorosalicylic acid compounds and related synthetic processes

Bruton's tyrosine kinase inhibitors

Processes for the preparation of 2-thiophenecarbonyl chloride

3,6-dichlorosalicylic acid compounds and related synthetic processes

Pyrido[4,3-d]pyrimidin-4(3H)-one derivatives as calcium receptor an...

1H-pyrazole and 1H-pyrrole-azabicyclic compounds for the treatment...

Azabicyclic compounds for the treatment of disease

Azabicyclic-phenyl-fused-heterocyclic compounds for treatment of di...

Azabicyclic-substituted-heteroaryl compounds for the treatment of d...

Azabicyclic-substituted fused-heteroaryl compounds for the treatmen...

Azabicyclic compounds for the treatment of disease

Substituted azabicyclic moieties for the treatment of disease

Fused bicyclic-N-bridged-heteroaromatic carboxamides for the treatm...

Substituted-aryl compounds for treatment of disease

N-(azabicyclo moieties)-substituted hetero-bicyclic aromatic compou...

Quinuclidine-substituted hetero-bicyclic aromatic compounds for the...

Patents Applicationslast 30 patents

Bruton's Tyrosine Kinase Inhibitors

PROCESSES FOR THE PREPARATION OF HETEROARYL CARBOXYLIC ACIDS

3,6-DICHLOROSALICYLIC ACID COMPOUNDS AND RELATED SYNTHETIC PROCESSES

Bruton's Tyrosine Kinase Inhibitors

PROCESSES FOR THE PREPARATION OF HETEROARYL CARBOXYLIC ACIDS

PROCESSES FOR THE PREPARATION OF 2-THIOPHENECARBONYL CHLORIDE

3,6-DICHLOROSALICYLIC ACID COMPOUNDS AND RELATED SYNTHETIC PROCESSES

Bruton's Tyrosine Kinase Inhibitors

3,6-DICHLOROSALICYLIC ACID COMPOUNDS AND RELATED SYNTHETIC PROCESSES

Bruton's Tyrosine Kinase Inhibitors

PYRIDO[4,3-d]PYRIMIDIN-4(3H)-ONE DERIVATIVES AS CALCIUM RECEPTOR AN...

PYRIDO [4,3-d] PYRIMIDIN-4 (3H) -ONE DERIVATIVES AS CALCIUM RECEPTO...

Exo-(t-butyl 2R(+))-2-amino-7-azabicyclo[2.2.1]heptane-7-carboxylat...

1H-pyrazole and 1h-pyrole-azabicyclic compounds for the treatment o...

Positive allosteric modulators of the nicotinic acetylcholine receptor

Azabicyclic-substituted fused heteroaryl compounds for the treatmen...

Azabicyclic-substituted fused heteroaryl compounds for the treatmen...

Fused bicyclic-N-bridged-heteroaromatic carboxamides for the treatm...

Treatment of attention defecit hyperactivity disorder

Quinuclidines-substituted-multi-cyclic-heteroaryls for treatment of...

Positive allosteric modulators of the nicotinic acetylcholine receptor

Positive allosteric modulators of the nicotinic acetylcholine receptor

Quinuclidine-substituted hetero-bicyclic aromatic compounds for the...

Azabicyclic compounds for the treatment of disease

Compounds as radioligands for the diagnosis of disease

Compounds having both alpha7 nicotinic agonist activity and 5HT3 an...

1H-pyrazole and 1H-pyrrole-azabicyclic compounds for the treatment...

Azabicyclic compounds for the treatment of disease

Substituted-aryl compounds for treatment of disease

Fused bicyclic-N-bridged-heteroaromatic carboxamides for the treatm...